Get started
Author

Yoshifumi Shimizu

The translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers
2014 · YUSUKE OJI, NAOYA TATSUMI, et al. · International Journal of Oncology · 84
Engraftment of Cultured Human Hematopoietic Cells in Sheep
1998 · Yoshifumi Shimizu, Makio Ogawa, et al. · Blood · 51
PDF
cDNA cloning of the murine 30-kDa protein homologous to the 32-kDa subunit of human replication protein A
1991 · Masashi Nakagawa, Satoshi Tsukada, et al. · Nucleic Acids Research · 14
Follicular lymphoma mimicking marginal zone lymphoma in lymph node: a case report.
2014 · Ikuo Matsuda, Yoshifumi Shimizu, et al. · PubMed Central · 9
Isolation of a cDNA clone encoding a novel membrane protein expressed in lymphocytes
1994 · Yoshifumi Shimizu, Hiroyasu Ogawa, et al. · FEBS Letters · 6
Regulation of Thy-1 Gene Expression by the Methylation of the 5′ Region of Thy-1 Gene and Intracellular Regulatory Factors in Immature B Cells
1992 · Yoshifumi Shimizu, Yoshihiro Oka, et al. · Immunological Investigations · 5
Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma
2021 · Satoshi Yoshihara, Kyoko Yoshihara, et al. · Hematology · 3
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion
2020 · Kyoko Yoshihara, Satoshi Yoshihara, et al. · Annals of Hematology · 3
Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study
2022 · Yoshihiro Hatta, Atsushi Sato, et al. · Blood · 2
[Therapy-resistant microcytic hypochromic anemia from malabsorption-related vitamin B6 deficiency after a gastrointestinal operation].
2005 · Mayumi Suzuki, Masashi Nakagawa, et al. · PubMed · 2
Transitory Expression of Thy-1 Antigen in Immature B Cell Lines
1992 · Yoshihiro Oka, Yoshifumi Shimizu, et al. · Immunological Investigations · 2
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma
2021 · Teruhito Takakuwa, Kensuke Ohta, et al. · Hematological Oncology · 1
Touch Smear Cytology in Epstein–Barr Virus‐Positive Nodal T‐ and NK ‐Cell Lymphoma: Cytological Features of This Rare, Aggressive Lymphoma
2026 · Shohei Matsuo, Norimitsu Tanaka, et al. · Cytopathology
[TARC levels in lenalidomide-induced rash during multiple myeloma treatment].
2026 · Kazumi Nagata, Yoshifumi Shimizu, et al. · PubMed
Author response for "Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma"
2021 · Teruhito Takakuwa, Kensuke Ohta, et al. · Publons reviews and discussion
Mixed-type autoimmune hemolytic anemia in a patient receiving nivolumab
2019 · Yoshifumi Shimizu, Norimitsu Tanaka, et al. · The Japanese Society of Hematology
[Cancer of the Ascending Colon Diagnosed at the Same Time as Breast Cancer Following Leukemia Treatment for Which Laparoscopic Surgery Was Performed-A Case Report].
2019 · Junya Yamazaki, Tetsuhiro Hamada, et al. · PubMed
Diffuse alveolar damage in a patient with Epstein Barr virus (EBV)-positive diffuse large B-cell lymphoma,severely low serum folate, and megaloblastic anemia: a case report of autopsy.
2014 · Ikuo Matsuda, Noriko Kajimoto, et al. · Europe PMC (PubMed Central)
再発濾胞性b細胞リンパ腫に対して,ゼバリン投与に続いてトレアキシン+リツキサン(b-r)治療
2013 · Yoshida Megumi, Takehito Imado, et al. · 臨床血液
非ホジキンリンパ腫の化学療法におけるRDI(relative dose intensity)と予後との関係
2010 · Okamoto Takahiro, Mitsuo Namiki, et al. · 臨床血液
Works count: 20
Citation count: 182
H-index: 5
I10-index: 3
Year
Topic
Type